Eupraxia Pharmaceuticals Growth Metrics (2023-2026) | EPRX

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Enterprise Value Growth (1y) (Quarter) -157.96%-67.75%22.28%13.98%-787.32%-136.99%-383.98%
Enterprise Value Growth (3y) (Quarter) -117.26%
Enterprise Value (QoQ) (Quarter) -80.71%33.56%58.87%-239.73%16.27%26.47%-324.24%9.26%-70.98%
FCF Margin Growth (1y) (Quarter) -426824.00-91117.00
FCF Payout Ratio Growth (1y) (Quarter) -91.75%1,511.77%184.52%19.66%-42.41%-1,177.62%
FCF Payout Ratio (QoQ) (Quarter) 96.20%-1,372.24%127.97%-11.86%120.05%-1,749.37%
Net Margin Growth (1y) (Quarter) -380072.00-116747.00
Return on Assets Growth (1y) (Quarter) 0.00-1.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.00
Return on Sales Growth (1y) (Quarter) -38.00-12.00